Find a Doctor or Practice Location

Are you a referring physician?
I am searching for a
Reset Form
Anuja Dokras, MD, PhD

Anuja Dokras, MD, PhD Physician

Director, Penn Polycystic Ovary Syndrome Center Medical Director, Reproductive Surgical Facility Professor of Obstetrics and Gynecology at the Hospital of the University of Pennsylvania

Dr. Dokras is employed by Penn Medicine.

About Dr. Anuja Dokras

Recognized by Best Doctors in America 2009 - 2012, 2017, 2018

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Clinical Specialties


  • Reproductive Endocrinology and Infertility

Programs & Centers:

Board Certification:

  • Obstetrics and Gynecology - Reproductive Endocrinology/Infertility, 2003
  • Obstetrics and Gynecology, 2000

Clinical Expertise:

  • Egg Donation
  • Female Infertility
  • In Vitro Fertilization (IVF)
  • Infertility
  • Polycystic Ovary Syndrome (PCOS)
  • Preimplantation Genetic Diagnosis (PGD)

Description of Clinical Expertise

Dr Dokras directs the Penn PCOS center which offers comprehensive gynecological, reproductive, dermatological, metabolic, nutritional and psychological care to women with PCOS. The program is present at 3701 Market St and Penn Medicine at Radnor with nutrition services available on-site.
She also Directs the Preimplantation Genetic Diagnosis program at Penn Fertility Care.

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Qualcare
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: University of Mumbai (formerly Bombay)
Residency: University of Mumbai, Seth G.S. Medical College
Residency: Yale-New Haven Hospital
Fellowship: Yale-New Haven Hospital


American College of Obstetricians and Gynecologists, National American Society for Reproductive Medicine, National Androgen Excess and PCOS Society, National Center for Research Excellence in PCOS, Guideline Development Group, International Center for Research Excellence in PCOS, International Advisory group, International Endocrine Society, International

Hospital Affiliation

Dr. Dokras is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.


Description of Research Expertise:

Research Interests: Dr Dokras directs the Penn Polycystic Ovary Syndrome (PCOS) trans disciplinary research program.

Keywords: PCOS, androgens, metabolic risk, mood disorders, HRQOL

Research Details:PCOS is the commonest endocrine disorder in reproductive age women with a prevalence of 8-15%. It is associated with significant gynecological, dermatologic, metabolic and psychiatric co-morbidities. Our research program has two main interests; understanding long term cardiovascular morbidity and risk of depression and anxiety disorders in PCOS. Both cardiovascular disease (CVD) and mood disorders are associated with significantly physical and emotional morbidity and add significantly to the financial burden of the healthcare system.

Our studies have shown that young women with PCOS have an increased risk of obesity, dyslipidemia, metabolic syndrome and subclinical atherosclerosis compared to age matched controls. We are currently interested in understanding the determinants of CVD risk by performing studies at both cellular level (lipid phenotyping, HDL function) and population levels (impact of steroid hormones on lipids, studying role of androgens in subclinical atherosclerosis). Some of these studies are conducted in collaboration with Dr Dan Rader.

Our second area of interest is to better understand the risk of lowered health related quality of life (HRQOL), and increased risk of anxiety and mood disorders in PCOS. We were among the first groups to comprehensively demonstrate a fourfold increased risk of depression and anxiety in PCOS. We are interested in understanding the impact of interventions such as lifestyle change, hormonal contraception, CBT on HRQOL, mood and anxiety disorders.

Selected Publications:

Roe A, Hillman J, Butts S, Smith M, Rader D, Playford M, Mehta NN, Dokras A.: Decreased cholesterol efflux capacity and atherogenic lipid profile in young women with PCOS. J Clin Endocrinol Metabol 99 (5): E841-847,2014.

Dokras A, Witchel SF: Are Young Adult Women with Polycystic Ovary Syndrome Slipping through the Healthcare Cracks? J Clin Endocrinol Metab 99 (5): 1583-1585,2014.

Milman L, DOkras A, Allison KC, Sarwer DV, Coutifaris C, Kris-Etherton PM, Kunselman AR, Stetter C, Dodson W, Legro RS.: Improvement in health related quality of life (HRQOL) following weight loss and/or normalization of hyperandrogenism with continuous oral contraceptives (OC) in women with PCOS. Fertil Steril 102 (3): e247,2014.

Dokras A: Cardiovascular Disease Risk in Women with PCOS. Steroids 78 (8): 773-776,2013.

Roe AH, Prochaska E, Smith M, Sammel M, Dokras A: Using the Androgen Excess-PCOS Society Criteria to Diagnose Polycystic Ovary Syndrome and the Risk of Metabolic Syndrome in Adolescents. J Pediatr : 2012.

Dokras A, Wild R: Anxiety disorders in women with PCOS: Systematic review and meta-analysis. Fertil Steril 97(1): : 2012.

Wild RA, Carmina E, Diamanti-Kandarakis E, Dokras A, Escobar-Morreale H, Futterweit W, Lobo RG, Norman RJ, Talbott E, Dumesic D: Prevention of cardiovascular disease in women with polycystic ovary syndrome: A position statement by the Androgen Excess and PCOS Society. J Clin Endocrinol Metab 95(5):2038-49 : 2010.

Kerchner A, Lester W, Stuart S, Dokras A: The risk of depression and other mental health disorders in women with PCOS: A longitudinal study. Fertil Steril 91(1):207-12 : 2009.

Hollinrake B, Abrue A, Maifield M, VanVoorhis B, Dokras A: Increased risk of depression in women with PCOS. Fertil Steril 87(6):1369-76 : 2007.

Shroff R, Kirschner A, Maifield M, Van Beek EJ, Jagasia D, Dokras A: Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis J Clin Endocirnol Metab 92:4609-614 : 2007.

Academic Contact Info

Penn Fertility Care
3701 Market Street, Suite 800

Philadelphia, PA 19104
Phone: (215) 615-0085
Patient appointments: 800-789-7366 (PENN)

Related Links